tirzepatide a glp 1 GLP-1 Medications for Weight Loss: Semaglutide vs vs Retat – Revolution Health & Wellness Bridging the gap between GLP1-receptor

The Wegovy-vs-Zepbound gap is consistent with mechanism: Wegovy activates only the GLP-1 receptor at a high obesity-management dose, while tirzepatide adds GIP receptor activity that may modestly buffer some GI effects

Approved injection sites Three areas are standard for subcutaneous peptide injections: Abdomen: The most common site

Patients with pre-existing gastrointestinal conditions such as gastroparesis, irritable bowel syndrome, or gastroesophageal reflux disease may experience more prolonged symptoms

Sensitive periods in the development of the brain and behavior

& Labigne, A

First, patients who have achieved target total weight on a GLP-1 but retain prominent visceral adiposity with metabolic implications